CREB1 and dementia: This was reflected in its stronger AChE-inhibitory activity, increased noradrenaline neurotransmission, the activation of BDNF/CREB signaling, and pronounced anti-apoptotic effects in the cortex and hippocampus of rats with experimental dementia.